Surgical Service, Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, SC; Division of Vascular and Endovascular Surgery, Medical University of South Carolina, Charleston, SC.
Division of Vascular Surgery, University of Vermont College of Medicine, Burlington, Vt.
J Vasc Surg. 2019 Sep;70(3):882-891.e2. doi: 10.1016/j.jvs.2018.11.049. Epub 2019 Mar 7.
The purpose of this study was to validate published Society for Vascular Surgery Vascular Quality Initiative (VQI) prediction models for patients with limb-threatening ischemia (LTI) undergoing open or endovascular revascularization for infrapopliteal occlusive disease.
We sought to validate our prior VQI LTI models for major adverse limb events (MALEs) and amputation-free survival (AFS) in a VQI new cohort undergoing open or percutaneous interventions from September 2014 through August 2016. Receiver operating characteristic curves were generated including the C statistic, and the predicted vs actual outcomes were correlated. The Hosmer-Lemeshow (HL) statistic was calculated to determine goodness of fit, and the Tjur R statistic was derived to demonstrate the degree to which the observed outcomes were accurately predicted by the models.
Of 15,576 open infrainguinal and 34,679 percutaneous interventions collected in the VQI during the 24-month interval, 8852 and 17,124, respectively, were performed for LTI, among which 4410 and 5116 specifically targeted the infrapopliteal vessels. MALEs and AFS were identified for 400 of 927 (43.1%) and 576 of 982 (58.7%) open procedures and 197 of 855 (23.0%) and 658 of 1115 (59.0%) percutaneous procedures, respectively. For open operation, the predictive ability of the model was poor for MALEs (C = 0.59; HL = 107; R = 0.03) and only marginally better for AFS (C = 0.69; HL = 130; R = 0.10). Similarly, for endovascular intervention, the model performed poorly for MALEs (C = 0.62; HL = 183; R = 0.06) and slightly better for AFS (C = 0.68; HL = 68; R = 0.11). Breaking AFS into its component determinants, the predictive ability of the open operation model for patient survival (C = 0.77; HL = 70; R = 0.15) surpassed that for limb salvage (C = 0.64; HL = 54; R = 0.05). For endovascular interventions, the survival model (C = 0.71; HL = 94; R = 0.11) also outperformed the limb salvage model (C = 0.67; HL = 28; R = 0.07). For both types of intervention, the actual MALE rate was lower and AFS was higher than predicted by the models.
The ability of reported VQI-derived models to accurately predict major outcomes for infrapopliteal LTI is limited and cannot be advocated for clinical decision-making at this time. Further study would be necessary to determine whether this is due to intraoperative and postoperative variables not accounted for in our models, absence of pertinent data points from the registry, or incomplete follow-up.
本研究旨在验证先前发表的血管外科学会(SVS)血管质量倡议(VQI)下肢缺血(LTI)患者的预测模型,这些模型用于接受开放或腔内血运重建治疗的下肢严重缺血患者的下肢严重缺血(LTI)患者。
我们试图在 VQI 新队列中验证我们先前的 VQI LTI 模型,这些模型用于 MajorAdverseLimbEvents(MALEs)和免于截肢的生存(AFS),这些患者接受了 2014 年 9 月至 2016 年 8 月的开放或经皮介入治疗。生成包括 C 统计量在内的接收器工作特性曲线,并对预测与实际结果进行相关性分析。计算 Hosmer-Lemeshow(HL)统计量以确定拟合优度,并得出 Tjur R 统计量以表明模型对观察结果的准确预测程度。
在 VQI 收集的 24 个月间隔内,有 15576 例开放的下肢和 34679 例经皮腔内干预用于治疗 LTI,其中分别有 8852 例和 17124 例用于治疗 LTI,分别有 4410 例和 5116 例专门针对腘下血管。在 927 例开放手术中有 400 例(43.1%)和 1115 例经皮手术中有 197 例(23.0%)发生 MALEs,在 982 例开放手术中有 576 例(58.7%)和 1115 例经皮手术中有 658 例(59.0%)发生 AFS。对于开放手术,模型对 MALEs 的预测能力较差(C=0.59;HL=107;R=0.03),对 AFS 的预测能力仅略有改善(C=0.69;HL=130;R=0.10)。同样,对于腔内干预,模型对 MALEs 的性能不佳(C=0.62;HL=183;R=0.06),对 AFS 的性能略好(C=0.68;HL=68;R=0.11)。将 AFS 分为其组成决定因素,开放手术模型对患者生存率(C=0.77;HL=70;R=0.15)的预测能力优于对肢体存活率(C=0.64;HL=54;R=0.05)的预测能力。对于腔内干预,生存模型(C=0.71;HL=94;R=0.11)也优于肢体存活率模型(C=0.67;HL=28;R=0.07)。对于两种类型的干预,实际的 MALE 发生率较低,AFS 高于模型预测。
报告的 VQI 衍生模型准确预测腘下 LTI 主要结局的能力有限,目前不能用于临床决策。需要进一步研究,以确定这是由于我们的模型中未考虑到的术中术后变量、注册表中缺少相关数据点,还是随访不完整。